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Abstract
In rodents and nonhuman primates subjected to spinal cord lesion, neutralizing the neurite growth inhibitor Nogo-A has been shown
to promote regenerative axonal sprouting and functional recovery. The goal of the present report was to re-examine the data on the
recovery of the primate manual dexterity using reﬁned behavioral analyses and further statistical assessments, representing
secondary outcome measures from the same manual dexterity test. Thirteen adult monkeys were studied; seven received an anti-
Nogo-A antibody whereas a control antibody was infused into the other monkeys. Monkeys were trained to perform the modiﬁed
Brinkman board task requiring opposition of index ﬁnger and thumb to grasp food pellets placed in vertically and horizontally oriented
slots. Two parameters were quantiﬁed before and following spinal cord injury: (i) the standard ‘score’ as deﬁned by the number of
pellets retrieved within 30 s from the two types of slots; (ii) the newly introduced ‘contact time’ as deﬁned by the duration of digit
contact with the food pellet before successful retrieval. After lesion the hand was severely impaired in all monkeys; this was followed
by progressive functional recovery. Remarkably, anti-Nogo-A antibody-treated monkeys recovered faster and signiﬁcantly better than
control antibody-treated monkeys, considering both the score for vertical and horizontal slots (Mann–Whitney test: P = 0.05 and
0.035, respectively) and the contact time (P = 0.008 and 0.005, respectively). Detailed analysis of the lesions excluded the possibility
that this conclusion may have been caused by differences in lesion properties between the two groups of monkeys.
Introduction
In the adult mammalian central nervous system, lesions lead to
persistent motor and sensory deﬁcits and the severity of these deﬁcits
is often correlated with the location and size of the injury. Transected
nerve ﬁbers do not spontaneously regrow in the central nervous
system of adult mammals, due in part to the presence of myelin-
associated neurite growth inhibitors such as Nogo-A (Filbin, 2003;
Schwab, 2004; Yiu & He, 2006). After section of the corticospinal
(CS) tract in adult rats, neutralizing Nogo-A with monoclonal
antibodies leads to enhanced axonal regrowth and compensatory
sprouting, in parallel with increased functional recovery (Schnell &
Schwab, 1990; Bregman et al., 1995; Thallmair et al., 1998; Bro¨samle
et al., 2000; Schwab, 2004; Liebscher et al., 2005).
Following incomplete spinal cord transection, in particular CS tract
injuries, nonhuman primates show spontaneous functional recovery to a
variable extent, depending on the lesion size and location, as well as on
the difﬁculty of the behavioral task (Galea & Darian-Smith, 1997a,b;
Sasaki et al., 2004; Schmidlin et al., 2004). Expanding upon data
previously reported in rats, adult nonhuman primates were subjected to
spinal cord injury and then treated with a neutralizing antibody against
Nogo-A. They exhibited enhanced functional recovery, in parallel with
increased sprouting in the CS tract, both caudal and rostral to the lesion
site (in macaques: Freund et al., 2006a, 2007; see also Fouad et al.,
2004 for anti-Nogo-A-enhanced regeneration of CS tract in marmosets
subjected to spinal cord lesion). These studies thus emphasize the
feasibility and importance of using adult nonhuman primate models of
spinal cord injury as a precursor to clinical trials in humans (Lemon &
Grifﬁths, 2005; Courtine et al., 2007), especially considering the more
similar organization of the CS system between nonhuman primates and
humans (as compared to rats; see Nudo & Frost, 2006).
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Some aspects of the study on anti-Nogo-A antibody-enhanced
functional recovery and CS axonal sprouting in macaques following
cervical cord lesion (Freund et al., 2006a) were, however, questioned
by two correspondence letters (Ho & Tessier-Lavigne, 2006; Tuszyn-
ski, 2006). Although we have responded to these criticisms (Freund
et al., 2006b), the aim of this report is to present additional data from
the behavioral analysis and a more detailed statistical analysis. They
clearly conﬁrm that anti-Nogo-A antibody treatment indeed enhances
the recovery of manual dexterity after cervical cord lesion (as compared
to control antibody-treated monkeys). In particular, we have introduced
a new parameter to measure manual dexterity, the ‘contact time’, which
is deﬁned as the time required to grasp the ﬁrst food pellet targeted by
the monkey. This new parameter evaluates manual dexterity more
accurately as it assesses the precision grip between the thumb and the
index ﬁnger, a prerogative of primates including humans (see Lemon &
Grifﬁths, 2005; Lemon, 2008 for review). Finally, we have included
measures to represent the estimated volume of the lesion in order to
more comprehensively describe the cervical lesion.
Materials and methods
The experiments were carried out on thirteen (3.5–6.9 years old) rhesus
(Macaca mulatta) or cynomolgus (Macaca fascicularis) monkeys
(male or female, 3.0–5.0 kg; see Table 1), in accordance to the Guide
for Care and Use of Laboratory Animals (ISBN 0-309-05377-3; 1996)
and approved by local veterinary authorities, including the ethical
assessment by the local (cantonal) Survey Committee on Animal
Experimentation and a ﬁnal acceptance delivered by the Federal
Veterinary Ofﬁce (BVET, Bern, Switzerland). The monkeys were
obtained from our own colony in our animal facility (Macaca
fascicularis) or were purchased (Macaca fascicularis and Macaca
mulatta) from a certiﬁed supplier (BioPrim; 31450 Bazie`ge; France),
with the authorization to import the animals delivered by the Federal
Veterinary Ofﬁce (BVET, Bern, Switzerland). Three recent reports
(Wannier et al., 2005; Freund et al., 2006a, 2007) describe the
behavioral task analyzed in the present report (‘modiﬁed Brinkman
board’ task; see Fig. 1E and also http://www.unifr.ch/neuro/rouiller/
Table 1. Results from cervical cord-lesioned monkeys included in the present study with identiﬁcation code
Anti-Nogo-A antibody
Control antibody (11C7) (hNogo)
Mk-CC Mk-CP Mk-CG Mk-CS Mk-CB Mk-CH Mk-AS Mk-AF Mk-AP Mk-AA Mk-AM Mk-AC Mk-AK
Species Mul. Fasc. Fasc. Mul. Fasc. Fasc. Mul. Mul. Fasc. Mul. Fasc. Fasc. Fasc.
‘Experimenter blind’ No Yes Yes No Yes Yes No No Yes No Yes Yes Yes
ICMS Yes – – Yes – – – Yes – – – – –
Hemisection extent (%) 38 45 51 63 75 90 41 56 58 72 80 85 86
Functional recovery (%)
Score (vert) 91 88 95 42 76 59 100 56 100 85 96 100 100
Score (horiz) 72 83 85 0 79 41 100 52 95 93 71 100 100
Contact time (vert) 100 50 77 36 38 22 93 57 89 100 78 84 100
Contact time (horiz) 59 54 100 0 29 32 100 72 100 86 90 100 100
Completeness of dlf
section
No No Yes* Yes Yes Yes No Yes Yes No Yes Yes Yes
– (BDA) (BDA) – (BDA) (BDA) (BDA) (BDA) (BDA) (BDA) (BDA) (BDA) (BDA)
Extent of lesion (%)
Dorsal column 0 14 39 47 31 72 9 2 48 100 74 44 58
CS and RS territory 61 64 70 87 93 100 48 73 100 57 100 100 100
Ventral column 30 24 0 19 38 60 12 0 8 43 5 100 100
Volume of lesion (mm3)
(scar in SMI-32 sections) 2.198 1.782 1.802 3.781 2.912 2.862 1.733 2.076 1.348 6.961 4.576 4.577 3.08
Antibodies: 11C7, mAb 11C7; hNogo, mAB hNogoA. Mul., macaca mulatta; Fasc., macaca fascicularis; ICMS, intracortical microstimulation; vert, vertical; horiz,
horizontal; dlf, dorsolateral funiculus; RS, rubrospinal tract. At the time of the experiment, monkeys were assigned codes that did not allow experimenters to
determine whether the animal was infused with the control or the anti-Nogo-A antibody. New names were assigned to the monkeys during the writing of the
manuscript to improve its readability. Under ‘Experimenter blind’ procedure, ‘Yes’ refers to monkeys for which the experimenters testing the monkeys and
measuring lesion extent did not know which antibody has been administered to the corresponding animal. Under ICMS, ‘Yes’ refers to the three monkeys subjected
to extensive ICMS sessions in the primary motor cortex (M1), whose data have been reported previously (Schmidlin et al., 2004, 2005). Functional recovery
(expressed as a percentage of the two behavioral parameters score and contact time) was assessed here based on the modiﬁed Brinkman board task, by comparing the
performance pre- and post-lesion, as explained in detail in the Materials and methods section for each of the two parameters. In the row ‘Completeness of dlf section’,
‘Yes’ and ‘No’ indicate whether the dlf was or was not completely transected unilaterally; ‘(BDA)’ indicates that completeness of the section of the dlf unilaterally
was assessed based on the BDA labeling of the CS tract immediately above the lesion, in addition to the location and extent of the lesion itself. *In the monkey
Mk-CG, a very small contingent of CS axons, labeled with BDA, escaped from the lesion ventrally. However, these few axons then ran ventrally in the white matter,
without giving rise to collaterals into the area immediately caudal to the lesion, and continued their trajectory further below to low thoracic segments. As a
consequence, these few preserved CS axons did not participate to the reconstruction of the CS tract in the segments immediately caudal to the lesion and therefore the
lesion of the dorsolateral funiculus was considered as complete in this animal too. For completeness, the extent of the lesion (as a percentage) is given separately for
three sub-territories of white matter in the lesioned hemi-cord. The three territories are: the dorsal column (from midline dorsally up to the dorsal rootlet entrance); the
ventral column (from midline ventral to the ventral rootlet exit) and, laterally, the territory between the dorsal and ventral rootlets corresponding mainly to the
territories occupied by the CS and RS tracts. A value of 100%, in the dorsal column for instance, means that 100% of the dorsal column sub-territory was lesioned in
the corresponding monkey. For Mk-AK(o) the anti-Nogo-A antibody treatment was delayed for 1 week. Nevertheless, an osmotic pump containing NaCl was
implanted immediately after lesion in order to be consistent with the protocol of the other monkeys. The data presented here in the 12 leftmost columns and rows 1–5
and 10–13 have been reported earlier (Freund et al., 2006a).
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Fig. 1. (A) Experimental time course, (B–D) lesion location and extent and (E) manual dexterity test. (A) Time course of experiment. AB pump, osmotic pump
implanted to deliver the antibody (control or anti-Nogo-A), at the time of lesion in 12 monkeys, over 4 weeks (purple horizontal line). The anti-Nogo-A antibody
infusion was delayed by 1 week in monkey Mk-AK (dark gray horizontal line), but saline was infused during the ﬁrst week (light gray horizontal line). The
neuroanatomical tracer BDAwas injected in the contralesional motor cortex (Freund et al., 2006a, 2007). (B and C) Reconstruction in the frontal plane, from sagittal
sections, of lesion extent at cervical level C7 ⁄ C8 in all monkeys. The grey area represents the grey matter of the cervical cord. Note that, due to the lesion, the hemi-
cord on the side of the lesion has been distorted. In four monkeys (*), the dorsolateral funiculus was not completely transected (see Table 1; also Freund et al.,
2006a). The lesions of twelve monkeys (all except Mk-AK) have been illustrated in previous reports (Freund et al., 2006a, 2007). (D) Photomicrograph of a sagittal
section of cervical cord taken from monkey Mk-CH, illustrating the lesion site. Rostral is to the left. The yellow contour outlines the scar of the lesion and the
penumbra zone is outlined in red. (E) Photographs illustrating the modiﬁed Brinkman board task used to assess manual dexterity pre- and post-lesion. The board
comprises 50 slots each containing a food pellet, 25 oriented vertically and 25 horizontally. The monkey grasps the pellet in vertical slots by performing the precision
grip (opposition of index ﬁnger and thumb) in a direction in the prolongation of the forearm (arrow in top panel). For the horizontal slots, the precision grip is
oriented along a nearly horizontal axis (arrow in bottom panel). Scale bar in D, 0.5 mm.
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motorcontcadre.htm), the surgical procedures (including transection of
the CS tract in the cervical cord at C7 ⁄C8 level), the treatment with the
anti-Nogo-A (n = 7) or control (n = 6) antibodies and the neuroana-
tomical investigations (including assessment of spinal lesion location
and extent). The antibodies’ characteristics and penetration in the
central nervous system have been reported elsewhere (Weinmann et al.,
2006; Freund et al., 2007). As previously reported in detail (Schmidlin
et al., 2004, 2005; Wannier et al., 2005; Freund et al., 2006a, 2007).
The present study includes the same twelve previously reported
monkeys (Freund et al., 2006a, 2007) and a thirteenth monkey
(Mk-AK), on which the experiment was completed later, and in which
anti-Nogo-A antibody infusion was initiated 7 days post-lesion
(Fig. 1A), in contrast to immediate infusion the day of the lesion in
the other six anti-Nogo-A antibody-treated monkeys. However, in this
thirteenth monkey (Mk-AK), although an osmotic pump was implanted
immediately after the lesion (as was the case for all the other monkeys),
only saline (NaCl 0.9%)was delivered during the ﬁrst week, and delayed
administration of the anti-Nogo-A antibody started 1 week post-lesion.
In all cases, the antibody was delivered for a period of 4 weeks.
The monkeys’ identiﬁcation codes refer to individual monkeys
(Table 1 in Freund et al., 2006a) and comprise, for the sake of clarity, a
‘C’ or an ‘A’ in the fourth character position, indicating whether the
monkey was control antibody-treated or anti-Nogo-A antibody-treated,
respectively. However, during the course of the experiments the animals
had different names from which the experimenter could not deduce
which antibody was infused, at least for the monkeys in which the
experimenter-blind procedure was applied (Table 1).
Monkeyswere housed in our animal facilities in rooms of 12 m3, each
usually containing 2–4monkeys free tomove in the room and to interact
with each other. In the morning, before behavioral testing, the animal
keeper placed themonkeys in temporary cages for subsequent transfer to
the primate chair. The monkeys had free access to water and were not
food-deprived. The rewards obtained during the behavioral tests
represented the ﬁrst daily access to food. After the tests, the monkeys
received additional food (fruits and cereals). The dexterity of each hand
was assessed in all lesioned monkeys with a ﬁnger prehension task,
speciﬁcally our modiﬁed Brinkman board quantitative test (Fig. 1E; see
also Rouiller et al., 1998; Liu & Rouiller, 1999; Schmidlin et al., 2004).
The tests were conducted using a Perspex board (10 cm · 20 cm)
containing 50 randomly distributed slots, each ﬁlled with a food pellet at
the beginning of the test (home-made behavioral apparatus). Twenty-
ﬁve slots were oriented horizontally and twenty-ﬁve vertically. The
dimensions of the slots were 15 mm long, 8 mm wide and 6 mm deep.
Retrieval of the food pellets required fractionated ﬁnger movements, in
order to produce an opposition of the index ﬁnger and the thumb, which
corresponds to the precision grip. This manual prehension dexterity task
was executed daily, alternatively with one and the other hand, four or
ﬁve times per week for several months before and after the unilateral
cervical cord lesion. A daily behavioral session typically lasted 60 min.
The performance of each hand was videotaped. In the present study, two
parameters were assessed: (i) the retrieval score, i.e. the number of wells
from which the food pellets were successfully retrieved and brought to
the mouth during 30 s, separately for the vertical and the horizontal
slots; (ii) the contact time, deﬁned as the time of contact (in s) between
the ﬁngers and the pellet, calculated for the ﬁrst vertical slot and the ﬁrst
horizontal slot targeted by the monkey in a given daily session (see also
paragraph 2 in the Results section). The contact time is comparable to
the prehension time as introduced by Nishimura et al. (2007) in parallel
to the present study, but for a different grasping task. In our previous
study, the retrieval score represented the primary outcomemeasure from
the modiﬁed Brinkman board task (Freund et al., 2006a) and was
determined by the total number of pellets retrieved in 30 s. In the present
study separate scores are provided for vertical and horizontal slots. The
contact time data and the bivariate and trivariate statistical analyses (see
below) represent secondary outcome measures from the modiﬁed
Brinkman board task, newly introduced in the present report.
After the monkeys reached a level of performance corresponding to
a plateau (usually after 30–60 days of initial training), we used the
score from 30–50 daily sessions to establish a pre-lesion behavioral
score for each monkey. A unilateral cervical cord lesion was
performed in thirteen monkeys as follows. Intramuscular injection of
ketamine (Ketalar Parke-Davis, 5 mg ⁄ kg, i.m.) was delivered
to induce anesthesia followed by an injection of atropine (i.m.;
0.05 mg ⁄ kg) to reduce bronchial secretions. In addition, before
surgery, the animal was treated with the analgesic Carprofen
(Rymadil, 4 mg ⁄ kg, s.c.). A continuous perfusion (0.1 ml ⁄min/kg)
through an intravenous catheter placed in the femoral vein delivered a
mixture of 1% propofol (Fresenius) and a 4% glucose solution
(1 volume of propofol and 2 volumes of glucose solution) to induce
a deep and stable anesthesia. The animal’s head was placed in a
stereotaxic headholder, using ear bars covered at their tip with local
anesthetic. The surgery was carried out under aseptic conditions, with
continuous monitoring of the following parameters: heart rate,
respiration rate, expired CO2, arterial O2 saturation and body
temperature. In early experiments, an extra intravenous bolus of
0.5 mg of ketamine diluted in saline (0.9%) was added at potentially
more painful steps of the surgical procedure (e.g. laminectomy)
whereas, in later experiments, ketamine was added to the perfusion
solution and delivered throughout surgery (0.0625 mg ⁄min ⁄ kg). The
animal recovered from anesthesia 15–30 min after the propofol
perfusion was stopped, and was treated post-operatively with an
antibiotic (Ampiciline 10%, 30 mg/kg, s.c.). Additional doses of
Carprofen were given daily (pills of Rymadil mixed with food) for
about 2 weeks after the surgery. Following the cervical cord lesion, the
animal was kept alone in a separate cage for a couple of days in order
to perform a careful survey of its condition. The details of surgical
Fig. 2. Quantitative assessment of manual dexterity based on the parameter score. (A and B) For two pairs of monkeys, comparison of retrieval scores obtained
before and after the lesion (day 0, represented by the vertical dashed line) derived from the modiﬁed Brinkman board task (number of pellets retrieved in 30 s), for
the hand affected by the cervical lesion. The control antibody-treated monkeys are in blue and the anti-Nogo-A antibody-treated monkeys in red. The scores were
plotted separately for vertical (dots) and horizontal (open symbols) slots. For each plot, the inset is a reminder of lesion location and extent. (C and D) Relationship
between the extent of hemi-cord lesion and degree of functional recovery of score (both as percentages) for the modiﬁed Brinkman board test for (C) vertically and
(D) horizontally oriented slots (blue circles for control antibody-treated monkeys and red squares for anti-Nogo-A antibody-treated monkeys). The dotted line
represents the tendency for an inverse correlation between recovery of score and lesion extent in the group of control antibody-treated monkeys (blue circles). In four
monkeys (*), the dorsolateral funiculus was not completely transected (see Fig. 1B and C). The monkey Mk-AK differed from the others in that the post-lesion
treatment was delayed by 1 week. (E and F) Illustration of the statistical analysis conducted on the data presented in C and D, respectively (for better visualization,
circles are for control antibody-treated monkeys and crosses are for anti-Nogo-A antibody-treated monkeys). The dashed line has been computed such as to minimize
the sum of distances between each data point and its projection onto the dashed line. Then, a solid line (in the green background rectangle) was drawn, orthogonal to
the previously deﬁned dashed line. Finally, the individual data points were projected on the solid line, along a direction parallel to the dashed line. In the green
background zone the data points on the solid line become independent of the axes of the initial plot. The green arrow points to an enlargement of the solid line onto
which the data points were projected (n = 6 for the control antibody-treated monkeys and n = 7 for the anti-Nogo-A antibody-treated monkeys). See Table 2 for
corresponding statistics.
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procedures and lesioning are available in previous reports (Schmidlin
et al., 2004, 2005; Wannier et al., 2005; Freund et al., 2006a, 2007).
After lesion, and following the period of recovery lasting generally
30–40 days, a post-lesion level of performance corresponding to a
plateau was established, based on a block of ten behavioral sessions
(usually the last ten sessions conducted). For the retrieval score,
functional recovery was expressed quantitatively as the ratio
(expressed as a percentage) of the post-lesion average retrieval score
value to the pre-lesion average score value. Because contact time was
measured only for the ﬁrst vertical and ﬁrst horizontal slots targeted by
the monkey, in order to minimize the impact of outliers the pre-lesion
and post-lesion contact time was assessed as the median value (Fig. 3C
and D). Considering that good performance is reﬂected by a short
contact time (in the pre-lesion condition), post-lesion performance
(recovery) was expressed quantitatively as the ratio (expressed as a
percentage) of the pre-lesion median contact time to the post-lesion
median contact time. For measures of both recovery of score and
contact time, if the calculated values exceeded 100% (i.e. post-lesion
performance was better than pre-lesion performance), the recovery
was considered to be complete and therefore expressed quantitatively
as 100%.
Besides the new behavioral parameter of contact time introduced
here, the present study also comprises a new analysis regarding the
lesion size. In our previous reports (Freund et al., 2006a, 2007), the
extent of the lesion was expressed as a percentage of the correspond-
ing hemi-cord surface, as assessed from a 2-D reconstruction of the
lesion in the transverse plane (see Fig. 1B and C). These standard
values of lesion extent have been considered here again in Figs 2 and 4
(see also Table 1). The present study expands upon these data by
further calculating the estimated volume of the cervical lesion in order
to consider the extent of the lesion in 3-D. After completion of the
post-lesion behavioral analysis (see below), the monkeys were killed
and prepared for histology as follows. Each monkey was pre-
anaesthetized with ketamine (5 mg ⁄ kg, i.m.) and given an overdose of
sodium pentobarbital (Vetanarcol; 90 mg ⁄ kg, i.p.). Transcardiac
perfusion of saline (0.9%) was followed by paraformaldehyde (4%
in phosphate buffer 0.1 m, pH 7.4), and 10, 20 and 30% solutions of
sucrose in phosphate buffer. The brain and the spinal cord were
dissected and stored overnight in a solution of 30% sucrose in
phosphate buffer. Frozen sections (50 lm thick) of the cervical cord
(approximately segments C6-T3) were cut in the parasagittal long-
itudinal plane and collected in three series for later histological
processing (see below).
Using an ad hoc function of the Neurolucida software (based on
the Cavalieri method; MicroBrightField, Inc., Colchester, VT, USA),
the volume of the cervical lesion (in mm3) was extrapolated from the
reconstructions of the lesion on consecutive histological longitudinal
sections of the cervical cord (see Table 1). The volume measurement
of the cervical lesion was conducted on one out of three series of
sagittal sections (50 lm thick), treated immunocytochemically with
the SMI-32 antibody (Covance, Berkeley, CA, USA), as previously
reported (Liu et al., 2002; Beaud et al., 2008; Wannier-Morino et al.,
2008). The epitope recognized by the SMI-32 antibody lies on
nonphosphorylated regions of neuroﬁlament protein and is only
expressed by speciﬁc categories of neurons (Campbell & Morrison,
1989; Tsang et al., 2006). The other two series of sections were
processed to visualize biotinylated dextran amine (BDA; Invitrogen,
Molecular Probe, Eugene, OR, USA) and ﬂuorescein dextran amine
(Invitrogen, Molecular Probe, Eugene, OR, USA) staining, resulting
from injections of BDA in the contralesional motor cortex and
ﬂuorescein dextran amine in the ipsilesional motor cortex (see Freund
et al., 2006a, 2007). Measurements of volume of the cervical lesion
were also conducted on sections processed for BDA but the lesion
contour was not as well deﬁned as on the SMI-32-stained sections,
where a clear scar region could be distinguished from a penumbra
lesion at the periphery of the lesion (yellow and red outlines in
Fig. 1D). The scar region was characterized by a dense ﬁbrous tissue
or granulous tissue forming a central zone of the lesion where the
SMI-32 staining was absent. The lesion volume data presented
(Table 1, Fig. 5) and considered for statistical analysis (Table 2) are the
measurements corresponding to the scar as seen on the SMI-32-stained
sections.
Because of the limited number of animals, two independent
statistical tests were used to compare the group of control antibody-
treated monkeys (n = 6) with the group of anti-Nogo-A antibody-
treated monkeys (n = 7). The ﬁrst test (based on a linear Fisher
discriminant analysis) takes into account one of the two parameters
reﬂecting the size of the lesion (i.e. the extent of hemi-cord lesion or
the volume of the lesion) and one of the four parameters reﬂecting the
percentage of functional recovery (score for vertical slots, score for
Table 2. P-values (Mann–Whitney test) for the statistical assessment of manual dexterity, comparing anti-Nogo-A antibody-treated monkeys (n = 7) and control
antibody-treated monkeys (n = 6)
P-values
Score (no. of pellets in 30 s) Contact time Lesion size
Vertical Horizontal Vertical Horizontal Vertical Horizontal
Lesion extent (% of hemi-cord)
(A) Bivariate analysis 0.05 0.035 0.008 0.005 – –
(B) Trivariate analysis – – – – 0.072 (n.s.) 0.044
Estimated lesion volume (scar in SMI-32 sections)
(C) Bivariate analysis 0.035 0.022 0.035 0.008 – –
(D) Trivariate analysis – – – – 0.146 (n.s.) 0.031
In A, (bivariate analysis on the extent of the lesion and the percentage of functional recovery), P-values are given for the recovery of score (see Fig. 2E and F; vertical
and horizontal slots, respectively) and recovery of contact time (see Fig. 4C and 4D; vertical and horizontal slots, respectively). In B, a trivariate rank test was
conducted on the three parameters recovery of scores, recovery of contact time and extent of lesion, as described in Materials and methods. The same two statistical
analyses used to treat the data in A and B were conducted on the data presented in C and D, but considering the estimated volume of the cervical lesion expressed
in mm3 instead of its extent as a percentage of hemi-cord. In C and D, similar statistical conclusions (P-values < 0.05) were obtained when taking as volume of the
lesion the values determined either from the lesion penumbra on SMI-32-stained sections or from the lesion as seen on BDA-stained sections. The size of the cervical
lesion is given by its extent expressed as a percentage of hemi-cord (A and B) or by its estimated volume in mm3 (C and D).
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horizontal slots; contact time for vertical slots or contact time for
horizontal slots), and thus is aimed at assessing the overlap or
segregation between the two groups of data (Figs 2E and F, and 4C
and D). The test provides maximal separation between the groups (see
Everitt, 2005) in the form of a linear function of the observed variables
such that the ratio of the between-groups variance to its within-group
variance is maximized. We used the R package to get the two lines
plotted in each of Figs 2E and F, and 4C and D. Line 1 (dashed line)
yields maximal separation and the projected samples are provided on
the orthogonal line 2 (solid line). For better visualization, line 2 was
proportionally enlarged and positioned vertically on the right side of
the graph (green arrows). With respect to the statistics, the sample size
does not permit an assumption of normality so we considered the
statistical problem of separation of the projected samples using the
nonparametric Mann–Whitney U-test. The obtained results are
summarized in Table 2 (row A, bivariate analysis).
The second statistical test (the trivariate analysis) examined the
three-dimensional data produced by differences in ‘recovery of scores’
(number of pellets retrieved, as illustrated in Fig. 2), ‘recovery of
contact time’ (time to grasp ﬁrst pellet, as illustrated in Fig. 4) and
‘lesion extent’, using a nonparametric multivariate rank test (Oja &
Randles, 2004). This test includes all three parameters and can be
considered an index of overall functional recovery. We assumed two
independent random samples from bivariate distributions F(x-c1) and
F(x-c2) located at centers c1 and c2, and tested the null hypothesis that
there was no effect of treatment (i.e. c1 = c2 versus the alternative c1
is different from c2). Data were transformed to make the test afﬁne-
invariant, to ensure a consistent performance over all possible choices
of coordinate system, and then projected onto a sphere where a rank
test was performed. As the law for this test is still unknown, we used
Monte-Carlo simulations to compute the P-value. The obtained results
are summarized in Table 2 (row B, trivariate analysis). A complete
description of these bivariate and trivariate statistical analyses,
applicable also to other types of lesions and to other behavioral tests
of manual dexterity in primates, will be reported elsewhere in a
methodological report. The same two statistical analyses (bivariate and
trivariate tests) were applied in a similar way as above for the
estimated volume of the lesion (Table 2, rows C and D).
Results
The experimental protocol is schematized in Fig. 1A. The location and
extent of the cervical cord lesion is represented for all monkeys in
Fig. 1B and C, including four animals in which the CS tract was not
completely transected (asterisks). A typical lesion is shown in Fig. 1D.
In three of thirteen monkeys (Mk-CS, Mk-CC and Mk-AF), an
intracortical microstimulation mapping of the M1 hand area was
conducted on both hemispheres (Schmidlin et al., 2004, 2005), a
procedure which may have partly reduced the recovery of their manual
dexterity.
Assessment of post-lesion recovery of manual dexterity:
retrieval scores
Following unilateral cervical injury, the dexterity of the ipsilesional
hand was severely impaired when assessed with the modiﬁed
Brinkman board test. In our previous report (Freund et al., 2006a)
only the total retrieval score was presented whereas here, scores
(number of pellets retrieved within the ﬁrst 30 s) are presented
separately for the vertical and horizontal slots (Fig. 2). Retrieval from
horizontal slots is expected to be more difﬁcult as it requires a postural
adaptation of the hand in addition to the precision grip. Indeed, even
when the control of the hand muscles is affected by the lesion, a hand
posture naturally similar to that normally used for grasping pellets
from the vertical slots is maintained (Fig. 1E). In contrast, the
horizontal slots require the monkey to actively position the hand such
that the axis between the extremities of the thumb and the index ﬁnger
is oriented horizontally (Fig. 1E). For instance, when performing the
precision grip with the right hand in the horizontal slots located on the
left half of the modiﬁed Brinkman board, the index ﬁnger must be
placed on the left and the thumb on the right (corresponding to a
pronation and abduction of the wrist); in contrast, when aiming for the
horizontal slots located on the right half of the modiﬁed Brinkman
board, the index ﬁnger must be positioned to the right of the thumb
(corresponding to a supination and adduction of the wrist).
For two monkeys tested in parallel by the same experimenter and
having similar lesions (Fig. 2A), the anti-Nogo-A antibody-treated
monkey (Mk-AM) exhibited faster and better recovery (96% and 71%
of pre-lesion scores for the vertical and horizontal slots, respectively)
than the control antibody-treated monkey (Mk-CH: 59% and 41%,
respectively). Similarly (Fig. 2B), for two other monkeys tested
in parallel, even though the anti-Nogo-A antibody-treated monkey
(Mk-AC) had a larger lesion, this monkey recovered faster and slightly
better (100% for both slot orientations) than the control antibody-
treated monkey (Mk-CG: 95% and 85% for the vertical and horizontal
slots, respectively).
The relationship between lesion extent and recovery of manual
dexterity (i.e. score) in all monkeys, for vertically (Fig. 2C) and
horizontally (Fig. 2D) oriented slots, shows that control antibody-
treated monkeys (blue circles) were characterized by a tendency to an
inverse correlation between lesion extent and percentage of recovery:
r = )0.632 for the vertical slots (P = 0.178) and r = )0.395 for the
horizontal slots (P = 0.438). In contrast, in most anti-Nogo-A
antibody-treated monkeys (red squares), the recovery was substan-
tially enhanced and, most importantly, reached 90–100% irrespective
of the lesion extent (Fig. 2C and D): r = 0.261 for the vertical slots
(P = 0.571) and r = 0.144 for the horizontal slots (P = 0.758).
In our previous report (Freund et al., 2006a), the statistical analysis
between the two groups of monkeys (anti-Nogo-A antibody- and
control antibody-treated monkeys) was based on a Mann–Whitney test
taking into consideration only the retrieval score, but not the lesion
extent, a crucial parameter in the present matter, especially for the
control antibody-treated monkeys (Fig. 2C and D). Thus, a new
statistical procedure was introduced here to consider both the retrieval
score and the lesion extent by plotting the data as in Fig. 2C and D but
computing a line deﬁned by minimizing the sum of distances between
each data point and its projection onto the line (dashed lines in Fig. 2E
and F). Then, data points were projected in the direction given by this
line onto an orthogonal line segment (green background zone where
the data points are independent of the axes of the initial plot). Finally,
the overlap between the two treatment groups of monkeys (blue circles
for control antibody-treated monkeys and red crosses for anti-Nogo-A
antibody-treated monkeys) was assessed using the Mann–Whitney
test. The anti-Nogo-A antibody-treated monkeys demonstrated signif-
icantly more recovery (as assessed by retrieval score) than the control
antibody-treated monkeys, when tested for the vertical slots (P = 0.05)
and for the horizontal slots (P = 0.035); see also,Table 2, row A.
Assessment of post-lesion recovery of manual dexterity:
contact time
The above data, based on the primary analysis of the modiﬁed
Brinkman board task (score given by the total number of pellets
retrieved in 30 s), reﬂect not only grasping ability but also other
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components of the movements such as the reaching phase, the variable
time to chew the reward before aiming for the next pellet, etc, thus
introducing more variability to the measure. In order to investigate
solely the capacity of ﬁne ﬁnger movement (i.e. the precision grip
between the index ﬁnger and thumb), the grasping phase was analyzed
by measuring the contact time from the video sequences. Contact time
is deﬁned as the time interval separating the ﬁrst contact of the index
ﬁnger with the food pellet and the ﬁnal successful grasp of the pellet
utilizing pad-to-pad opposition of the index ﬁnger and thumb (i.e.
when the pellet leaves the slot), for, respectively, the ﬁrst vertical and
the ﬁrst horizontal slots targeted by the monkey’s hand.
For the same two pairs of monkeys as in Fig. 2, the contact time was
plotted as a function of time (in days) pre- and post-lesion (Fig. 3A and
B). Before lesion, all monkeys exhibited a short and relatively stable
Fig. 4. Relationship between the parameter contact time and hemi-cord lesion extent. (A and B) Relationship between extent of hemi-cord lesion and functional
recovery for the contact time needed for the ﬁrst successful picking. Same conventions as in Fig. 2C and D. The dotted line represents the tendency for an inverse
correlation between recovery of contact time and lesion extent in the group of control antibody-treated monkeys (blue circles). (C and D) Graphic illustration of the
statistical analysis conducted on the contact time data for (C) the vertical and (D) the horizontal slots. Same conventions as in Fig. 2E and F. See Table 2 for
corresponding statistics.
Fig. 3. Quantitative assessment of manual dexterity based on the parameter contact time. (A and B) The contact time (in s), i.e. the time needed for one successful
retrieval using the opposition of index ﬁnger and thumb in a pad-to-pad fashion, was plotted for two pairs of monkeys as a function of time (days) with respect to the
lesion. The control antibody-treated monkeys are in the left column (blue) and the anti-Nogo-A antibody-treated monkeys in the right column (red). Data are shown
before the lesion and over the post-lesion weeks for the vertically (ﬁlled symbols) and horizontally (open symbols) oriented slots. On the abscissa, day 0 (vertical
dashed line) is for the time point of the cervical lesion. In rare cases shortly after the lesion, the contact time may have exceeded 4 s but was plotted here as 4 s. For
each plot, the inset on the upper right is a reminder of lesion location and extent. (C and D) The contact times measured before lesion and within the last ten post-
lesion sessions in the plateau reﬂecting stable recovery are distributed in form of box-and-whisker plots. For each monkey, the left box is for pre-lesion data whereas
the right box is for post-lesion data. In box and whisker plots, the thick horizontal line in the box corresponds to the median value and the top and bottom of the box
are for the 75th and 25th percentile values respectively. The top extremity of the whisker above the box is the largest data point included in the range going from the
75 percentile up to a level deﬁned as the sum of the 75 percentile plus 1.5 times the inter-quartile distance. The bottom extremity of the whisker below the box is the
smallest data point included in the range going from the 25 percentile down to a level deﬁned as the 25 percentile minus 1.5 times the inter-quartile distance.
*P <= 0.05 between pre- and post-lesion contact time values (Mann–Whitney test); n.s., nonsigniﬁcant difference (P > 0.05). Note in panel D that Mk-CS did not
recover the ability to grasp the pellet post-lesion from horizontal slots and therefore the contact time was set to the upper time limit of the test, i.e. 4 s.
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contact time. Immediately following the lesion, contact time increased
substantially and became more variable from one daily session to the
next. However, the anti-Nogo-A antibody-treated monkeys (red
symbols in Fig. 3A and B) recovered faster and better than the
control antibody-treated monkeys (blue symbols in Fig. 3A and B).
The contact time in the vertical and horizontal slots has been plotted
for all thirteen monkeys (box-and-whisker plots in Fig. 3C and D),
showing the pre-lesion values adjacent to the post-lesion values after
recovery. In four of the six control antibody-treated monkeys, for both
the vertical and the horizontal slots, contact time values were
signiﬁcantly longer post-lesion than pre-lesion (Mann–Whitney,
P < 0.05; Fig. 3C and D), corresponding to an incomplete recovery.
In contrast, the post-lesion contact time values of six of the seven anti-
Nogo-A-treated monkeys were not statistically signiﬁcantly different
(Mann–Whitney, P > 0.05) from pre-lesion values (Fig. 3C and D),
thus reﬂecting substantial functional recovery.
Contact time values, expressed as percentage recovery, were plotted
as a function of lesion extent for the vertical and horizontal slots,
respectively (Fig. 4A and B). The percentage recovery of contact time
was inversely correlated with the lesion extent in the control antibody-
treated monkeys for the vertical slots with r = )0.840 (P = 0.036)
whereas there was only a trend for the horizontal slots (r = )0.511;
P = 0.301). In contrast, such a trend for an inverse correlation was
absent in the anti-Nogo-A antibody-treated monkeys: r = 0.191 for the
vertical slots and r = 0.162 for the horizontal slots (P = 0.682 and
P = 0.729, respectively; red symbols in Fig. 4A and B). In other
words, the anti-Nogo-A antibody-treated monkeys exhibited a contact
time recovery mostly independent of the lesion extent. The data were
processed statistically as described above (Fig. 2E and F). Contact
time for the anti-Nogo-A antibody-treated monkeys was statistically
signiﬁcantly different from that of the control antibody-treated
monkeys for both the vertical slots (Mann–Whitney: P = 0.008;
Fig. 4C) and the horizontal slots (P = 0.005; Fig. 4D; see also Table 2,
row A). Improvements in contact time were thus signiﬁcantly better in
the anti-Nogo-A antibody-treated monkeys than in the control
antibody-treated monkeys using a statistical approach that considered
the lesion extent.
As outlined in Materials and Methods (second statistical test), the
overall functional recovery was assessed using a trivariate rank test on
recovery of score, recovery of contact time and lesion extent, revealing
a statistically signiﬁcant difference between the anti-Nogo-A anti-
body-treated monkeys and control antibody-treated monkeys for the
horizontal slots (P = 0.044) but not for the vertical slots (P = 0.072);
see also Table 2, row B.
As compared to our recent report (Freund et al., 2006a), one
additional monkey was introduced here (Mk-AK); in this one the anti-
Nogo-A antibody was not infused until 1 week post-lesion. This
monkey exhibited complete recovery of function, as assessed by both
the score (Fig. 2C and D) and the contact time (Fig. 4A and B), similar
to what was observed in most anti-Nogo-A antibody-treated monkeys
that received immediate post-lesion treatment.
Re-examination of the behavioural data as a function of the
volume of the cervical lesion
In our previous reports (Freund et al., 2006a, 2007) and for data
presented above, lesion extent was evaluated on the basis of the
surface of the territory of injury expressed as a percentage of the
corresponding hemi-cord surface, as seen on a 2-D reconstruction of
the lesion in a single transverse plane of the cervical cord (Fig. 1B and
C). Although the plane of reconstruction was taken at the level of
maximal lesion extent in the transverse plane of the spinal cord, the
percentage values of lesion extent as exhibited in Figs 2 and 4 did not
account for the size of the lesion along other axes. Moreover, our
previous report (Freund et al., 2007) provided evidence that a part of
the anti-Nogo-A antibody-enhanced density of CS axon arbors that
were found caudal to the lesion had arisen from sprouting of the CS
tract rostral to the lesion, and that had possibly migrated around the
lesion site (for instance in the gray matter left intact by the injury).
Thus, the expression of the lesion extent as a percentage of hemi-cord
surface, as derived from a 2-D representation of the lesion as in
Fig. 1B and C, may not fully account for the distance covered by
regenerating axons. Therefore, as a complementary approach, the
present study includes a 3-D analysis of the cervical lesion in order to
present the estimated volume of the lesion, derived from an
extrapolation on consecutive histological sections (see Materials and
methods). Across monkeys, the estimated volume of the cervical
lesion ranged from 1.348 to 6.961 mm3 (Table 1). In the control
antibody-treated monkeys, the mean ± SD estimated volume of the
lesion was 2.556 ± 0.77 and the median value 2.53 mm3 whereas, in
the anti-Nogo-A antibody-treated monkeys, the mean estimated
volume was 3.478 ± 2.01 and the median value 3.08 mm3. The
estimated volume of the cervical lesion was thus somewhat larger in
the group of anti-Nogo-A antibody-treated monkeys than in the
group of control antibody-treated monkeys, but this difference was
not statistically signiﬁcant (Mann–Whitney test, P > 0.05). Similarly,
the trivariate statistical approach applied to the percentage lesion
extent, the volume of scar and the volume of penumbra did not show
a statistically signiﬁcant difference between the control antibody-
treated monkeys and the anti-Nogo-A antibody-treated monkeys
(P = 0.84).
Recovery of score (number of pellets retrieved in 30 s) was plotted
as a function of the estimated volume of the lesion, for the vertical and
horizontal slots, respectively, in Fig. 5A and B. Similarly, recovery of
contact time was plotted as a function of the estimated volume of the
lesion in Fig. 5C and D, for the vertical and horizontal slots,
respectively. Functional recovery (both for the score and the contact
time) was more prominent in anti-Nogo-A antibody-treated monkeys
(largely irrespective of the estimated volume of the lesion) than in
control antibody-treated monkeys (Fig. 5). In the latter group, the
functional recovery for the score was inversely correlated with the
estimated volume of the lesion for both the vertical slots (r = )0.937;
P < 0.006) and the horizontal slots (r = )0.872; P < 0.024). Still in
the group of control antibody-treated monkeys, the functional
recovery for the contact time was inversely correlated with the
estimated volume of the lesion in the horizontal slots (r = )0.899;
P = 0.015) whereas this was only a trend in the vertical slots
(r = )0.606; P = 0.202). In the anti-Nogo-A antibody-treated mon-
keys (Fig. 5), recovery was not correlated with the estimated volume
of the lesion, as indicated by coefﬁcients of correlation of r = 0.026,
r = 0.097, r = 0.293 and r = )0.148 in panels A, B, C and D,
respectively, of Fig. 5; these were not statistically signiﬁcant
(P > 0.5).
To compare the recovery between the two groups of monkeys, the
same statistical analysis was conducted on the plots of Fig. 5A–D as
previously done in Figs 2E and F, and 4C and D. The results of the
bivariate statistical analysis (functional recovery of either score or
contact time as a function of the estimated volume of the lesion) are
given in Table 2, row C. Considering both score and contact time, the
statistical analysis conﬁrms the notion of a signiﬁcant enhancement of
functional recovery in the anti-Nogo-A antibody-treated monkeys as
compared to the control antibody-treated monkeys, when grasping was
tested in both the vertical slots and the horizontal slots (see P-values in
Table 2, row C). The trivariate analysis conducted on the parameters
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score, contact time and estimated volume of the lesion (Table 2, row
D) showed that the difference between the two groups of monkeys was
statistically signiﬁcant for the horizontal slots (P = 0.031) but not for
the vertical slots (P = 0.146).
Speciﬁc behavioral and tract-tracing data derived from monkey
Mk-AK treated with anti-Nogo-A antibody after a delay
of 1 week post-lesion
In our previous report (Freund et al., 2007), tract-tracing data were
reported from nine monkeys subjected to cervical lesion. Behavioral
data on the modiﬁed Brinkman board had been presented for eight of
these animals (Freund et al., 2006a). Four additional monkeys
considered in Freund et al. (2006a) were not suitable for tract-tracing
analysis of the CS tract. As mentioned above, the present study
includes a new monkey (Mk-AK) subjected to a cervical lesion and
treated with anti-Nogo-A antibody, but the onset of antibody
administration was delayed by 1 week (Fig. 1A). For completeness
of data presentation regarding this particular monkey Mk-AK, contact
time data, the most pertinent manual dexterity parameter, are presented
in Fig. S1A. Post-lesion, Mk-AK shows a 100% recovery of contact
time. The reconstruction of the density of BDA-labeled CS axons
rostral and caudal to the cervical lesion is shown in Fig. S1B. From
such reconstructions, the axonal swellings caudal to the lesion were
counted and normalized according to the total number of CS axons
labeled at C5 level, as done for the animals in our previous reports
(Freund et al., 2006a, 2007). Furthermore, the CS axons crossing
midline at the level of C5 were also counted and normalized as above.
Fig. 5. Relationship between the behavioural parameters score and contact time as a function of the estimated volume of the cervical lesion. (A and B) Relationship
between the degree of functional recovery of score (as a percentage) for the modiﬁed Brinkman board test and the estimated volume of the cervical lesion for (A)
vertically and (B) horizontally oriented slots (blue circles for control antibody-treated monkeys and red squares for anti-Nogo-A antibody-treated monkeys). (C and
D) Relationship between the degree of functional recovery of contact time needed for the ﬁrst successful retrieval and the estimated volume of the cervical lesion, for
(C) vertically and (D) horizontally oriented slots (blue circles for control antibody-treated monkeys and red squares for anti-Nogo-A antibody-treated monkeys). In
each panel, the dotted line represents the tendency for an inverse correlation between recovery of score or contact time and the estimated volume of the lesion in the
group of control antibody-treated monkeys (blue circles). See Table 2 for corresponding statistics. In four monkeys (*), the dorsolateral funiculus was not completely
transected (see Fig. 1B and C). The monkey Mk-AK differs from the others because post-lesion treatment was delayed by 1 week.
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These two parameters for Mk-AK (normalized number of axonal
swellings caudal to the lesion and normalized number of CS axons
crossing midline at C5) are plotted in Fig. S1C and D as a function of
lesion extent, together with the same data reported earlier for eight
other monkeys (Freund et al., 2007). For both parameters, data from
Mk-AK aligned with the cluster of data points formed by the other
anti-Nogo-A antibody-treated monkeys (red squares), largely sepa-
rated from the cluster of data points formed by the control antibody-
treated monkeys (blue circles).
Discussion
The present study re-examines the behavioral recovery of 13 adult
macaque monkeys with unilateral transection of the cervical spinal
cord and subsequent infusion of an anti-Nogo-A or a control antibody.
Using additional behavioral criteria and more detailed statistical
methods, we conﬁrmed our initial observations (Freund et al., 2006a)
clearly showing that anti-Nogo-A antibody treatment promotes
functional recovery from cervical hemisection.
The present study adds signiﬁcant information above and beyond
our ﬁrst report (Freund et al., 2006a). First, our initial statistical
comparison of score (number of pellets retrieved within 30 s, which
represents a ﬁrst outcome measure from the manual dexterity test)
between the two groups of monkeys was univariate, taking into
account only the score without considering the variability of the extent
of the lesion (Freund et al., 2006a). Whereas such a univariate
statistical approach did not impact much on the group of anti-Nogo-A
antibody-treated monkeys (in which the extent of recovery was largely
independent of the size of the lesion), this is not true for the group of
control antibody-treated monkeys, where the extent of recovery tends
to be inversely correlated to the lesion extent (Figs 2C and D, 4A and
B, and 5A–D). The bivariate statistical analysis (Figs 2E and F, and 4C
and D, and Table 2, rows A and C, representing a secondary outcome
measure from this behavioral investigation) is thus more appropriate,
as it integrates the two variables. Second, the most original and
valuable contribution of the present study is the introduction of the
parameter contact time, which represents a very sensitive and robust
measure of hand and ﬁnger dexterity (contact time is also a secondary
outcome from the modiﬁed Brinkman board task). Indeed, considering
the score data as a function of lesion extent (% of hemi-cord) in the
bivariate analysis, the difference between the two groups of monkeys
was signiﬁcant at a P-value of 0.038 when the vertical and horizontal
slots were cumulated (Freund et al., 2006a) or at a P-value of 0.05 and
0.035 for the vertical slots and horizontal slots, respectively (Fig. 2E
and F; Table 2, row A). Contact time data yielded a more signiﬁcant
difference between the control antibody- and the anti-Nogo-A
antibody-treated monkeys, with a P = 0.008 for the vertical slots
and P = 0.005 for the horizontal slots (Fig. 4C and D; Table 2, row A).
Similarly, in the bivariate statistical analysis taking into account the
estimated volume of the lesion (Table 2, row C), the difference
between the two groups of monkeys was signiﬁcant for both the
contact time data and the score data for the two slot orientations
(Table 2, row C). We believe that contact time data are more speciﬁc
and robust than the score data because contact time reﬂects more
speciﬁcally the function (ﬁnger dexterity) affected by the cervical
lesion, whereas the score data are contaminated by other components
of the overall behavior such as reaching, retrieval, food release to the
mouth, chewing, etc. As shown earlier, the anti-Nogo-A antibody-
enhanced recovery was paralleled by an increase in corticospinal
axonal sprouting both caudal and rostral to the lesion (Freund et al.,
2006a, 2007; see also Fig. S1); it is possible that enhanced sprouting
in other descending tracts may also play a role.
Regarding the possible role played by descending tracts other than
the CS tract, it is important to emphasize that, in our studies (Freund
et al., 2006a, 2007; present study), only the CS tract was labeled with
BDA. As a consequence, quantitative data were available only for the
CS tract (see e.g. Beaud et al., 2008). The question of the possible
contribution of the other descending tracts can thus be addressed only
indirectly. The lesion extent as seen on a transverse plane of the
cervical cord can be subdivided into different sectors of the white
matter (Table 1), corresponding to the dorsal column (containing the
ascending sensory inputs of the dorsal column system; see below), the
lateral column (containing the main portion of the CS and rubrospinal
tract) and the ventral column (containing the tectospinal, reticulospinal
and vestibulospinal tracts; see Lemon, 2008 for a review on the
location of the descending tracts in the monkey). Although the number
of animals in the present study is substantial for a nonhuman primate
study, it remains, unfortunately, insufﬁcient to address the individual
role played by the various descending tracts in the recovery of
function. First, the functional roles of the various descending tracts are
not fully independent (Lemon, 2008). Second, it would be necessary
to have several animals exhibiting similar CS tract lesions but different
lesions of the other descending tracts, a condition that was not met in
the present data. Tentatively, in the control antibody-treated monkeys,
the two animals exhibiting the least spontaneous recovery had lesions
with large estimated volumes (Table 1 and Fig. 5) and were thus
possibly subjected to a lesion that affected more of the ventral column,
the dorsal column and the rubrospinal tract than in the other monkeys
(Fig. 1B). In contrast, in the anti-Nogo-A antibody-treated animals, the
monkeys Mk-AF and, to a lesser extent, Mk-AM, showing less
prominent functional recovery than the other ﬁve monkeys, did not
exhibit lesions that speciﬁcally affected descending tracts other
than the CS tract. In conclusion, the descending tracts other than the
CS tract are likely to play a role in functional recovery, at least in
control antibody-treated monkeys, but additional monkeys with a
wider range of lesion properties will be needed to address this issue in
more detail.
An intrinsic limitation of such lesion studies is the considerable
variability between individuals, the impact being even more substantial
given an animal model (monkeys) for which ethical considerations
restrict the number of available animals. In rodents, the inter-individual
variability is dealt with in part by increasing the number of animals. In
the present study, inter-individual variability is due to the inevitable
variations in location and extent of the lesion, as well as to parameters
related to monkeys’ motivational and attentional states. As stated
above, the variability related to lesion extent was taken into account
here statistically, in contrast to our previous report (Freund et al.,
2006a), by introducing the bivariate, nonparametric statistical test
assessment of both the percentage of recovery and lesion size. The
statistical analysis was extended by introducing a trivariate statistical
test, representing an overall degree of recovery assessed with two
different behavioral measures, and integrating the impact of the lesion
extent expressed as a percentage of the hemi-cord. The results of the
trivariate approach conﬁrms the observation of enhanced functional
recovery of manual dexterity in anti-Nogo-A antibody-treated monkeys
when retrieving pellets from the horizontal slots but not from the
vertical slots (Table 2, row B; P = 0.072 for vertical slots and
P = 0.044 for the horizontal slots). In the trivariate statistical analysis,
when considering the lesion size assessed as the estimated volume of
the lesion and the same two behavioral measures (Table 2, row D), the
difference between the two groups of monkeys was signiﬁcant for the
horizontal slots (P = 0.031) but not for the vertical slots (P = 0.146).
As compared to our previous report (Freund et al., 2006a), in which
the score data in the modiﬁed Brinkman board task were cumulated
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for the vertically and horizontally oriented slots, the present study
provides a separate description for the two slot orientations (Fig. 1E),
with respect to both the score data (Figs 2 and 5; Table 2) and the
contact time data (Figs 3–5 and Table 2). For both parameters (score
and contact time), in the anti-Nogo-A antibody-treated monkeys (red
squares in Figs 2C and D, 4A and B and 5), the post-lesion recovery
was generally similar for vertically and horizontally oriented slots,
close to 90–100% (except Mk-AF for vertical score, Mk-AF and
Mk-AM for horizontal scores; Mk-AF and Mk-AM for vertical contact
times and Mk-AF for horizontal contact time). The effect of the anti-
Nogo-A antibody treatment was somewhat more prominent for
the horizontal slots than for the vertical slots, as suggested by the
bivariate and the trivariate statistical analyses where lower P-values
were obtained when comparing the two groups of monkeys for
the horizontal slots than for the vertical slots (Table 2). Along this line,
the two control antibody-treated monkeys with the longest contact
times for the horizontal slots (Fig. 3D) had the most damage to the
lateral part of the dorsal column (Fig. 1C). This observation is
consistent with the notion that sensory loss disrupts precision grip
(Gilman & Denny-Brown, 1966; Johansson & Westling, 1984;
Glendinning et al., 1992; Leonard et al., 1992). In contrast, the two
anti-Nogo-A antibody-treated monkeys with complete CS tract lesions
as well as damage to the lateral part of the dorsal column (Mk-AM and
Mk-AP; Fig. 1C) did not show such an increase in contact time
variability post-lesion for the horizontal slots (Fig. 3D). The anti-
Nogo-A antibody treatment may thus also have reduced the impact of
sensory deﬁcits on precision grip and not merely acted on the motor
components of the manual dexterity depending either on the CS tract
or on other descending tracts.
As compared to the report of Freund et al. (2006a), a thirteenth anti-
Nogo-A antibody-treated monkey (Mk-AK) was included here. This
animal differed from the other six anti-Nogo-A antibody-treated
monkeys in an onset of anti-Nogo-A antibody infusion delayed by
1 week. The goal of this manipulation was to test the impact of such a
delay, which may be required in the case of spinal cord-injured
patients in order to allow their stabilization and precise diagnosis
before any intervention. These preliminary data in a single monkey
suggest that a delay of 1 week does not negatively impact the anti-
Nogo-A antibody-enhanced recovery, although conﬁrmation on a
larger number of animals with delayed infusion is needed. Concerning
the monkey Mk-AK, one may argue that this animal exhibited good
functional recovery because it was not affected by the early (i.e. during
the ﬁrst week) infusion of any ﬂuid around the lesion in contrast to the
other 12 monkeys, which may be detrimental to the recovery. This
argument can be ruled out as the monkey Mk-AK received a perfusion
of saline during the ﬁrst week before administration of the anti-Nogo-
A antibody from week 2 to week 5 post-lesion (see Fig. 1A). For this
reason, inclusion of Mk-AK in anti-Nogo-A antibody treatment group
is justiﬁed. As far as the functional recovery is concerned, delaying
infusion of anti-Nogo-A antibody by 1 week could make recovery
more difﬁcult, as compared to animals treated immediately. However,
the optimal time window for efﬁcient anti-Nogo-A antibody treatment
in monkeys remains to be determined.
In this report, we present new behavioral measures of manual
dexterity (i.e. the contact time in the modiﬁed Brinkman board task)
coupled with new statistical analyses, constituting a sensitive and
robust assessment of functional recovery after cervical lesion in a
nonhuman primate model of spinal cord injury, in spite of the
inevitable inter-individual variability related to lesion characteristics.
As illustrated in Table 1, the lesion extent expressed as a percentage of
the corresponding hemi-cord seen in the transverse plane is similar for
the two groups of monkeys, as is the percentage of the dorsal column,
lateral column and ventral column injured. Furthermore, considering
that our newly introduced estimates of lesion volume show no
signiﬁcant differences between treatment groups, the enhanced
functional recovery in the anti-Nogo-A antibody-treated monkeys
clearly cannot be explained by less extensive lesions in this group of
monkeys as compared to those in the control antibody-treated group.
Although the lesion size, derived from hemi-cord cross-sections
(Fig. 1B and C) and expressed as extent of the lesion given as the
percentage of hemi-cord affected, is limited to one axis it is
nevertheless useful to assess which descending and ascending tracts
have been affected by the lesion. To take into account the size of the
lesion overall, the newly calculated lesion volume represents an
important complementary assessment of lesions, in particular with
respect to the possible distance that regenerating nerve ﬁbers must
traverse in order to establish new connections.
Finally, the new measure contact time (of the ﬁngers with the ﬁrst
pellet) focuses on ﬁnger dexterity, a characteristic unique to primates
(see Lemon & Grifﬁths, 2005; Lemon, 2008 for review), by assessing
the retrieval time itself without taking into account the less controlled
inter-pellet time interval. The inter-individual variability mainly due to
lesion properties is in line with the strong variability also encountered
in spinal cord-injured patients, thus making the present behavioral
model in monkeys clinically highly relevant. In spite of this inter-
individual variability, the behavioral measure of contact time and the
multivariate statistical assessments considering the lesion extent in
volume clearly demonstrate that anti-Nogo-A antibody treatment
indeed promoted functional recovery from spinal cord lesion in
primates. The anti-Nogo-A antibody treatment thus represents a
promising approach for improved clinical intervention in spinal cord-
injured patients, most probably in combination with complementary
strategies.
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